| Sales and service revenue | 14.26a | 12.78a |
| Influenza pandemic facility reservation fees | 0.17a | 0.16a |
| Royalties and license revenue | 0.26a | 0.24a |
| Other income | 0.11a | 0.14a |
| Total operating revenue | 14.8a | 13.31a |
| Cost of sales | -7.13a | -6.49a |
| Gross profit | 7.67a | 6.83a |
| Research and development expenses | -1.43a | -1.27a |
| Selling and marketing expenses | -1.57a | -1.48a |
| General and administration expenses | -0.86a | -1.01a |
| Total expenses | -3.86a | -3.76a |
| Operating profit (EBIT) | 3.81a | 3.07a |
| Finance costs | -0.48a | -0.44a |
| Finance income | 0.04a | 0.04a |
| Profit before income tax expense | 3.38a | 2.66a |
| Income tax expense | -0.66a | -0.42a |
| Net profit for the year | 2.71a | 2.24a |
| Net profit for the year attributable to: | 2.71a | 2.24a |
| Shareholders of CSL Limited | 2.64a | 2.19a |
| Non-controlling interests | 0.07a | 0.05a |